EFDID: 544397EFD: View Filing

Issuer: OS Therapies Inc (0001795091) - D

Accession: 0001795091-25-000004 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001795091
  • Entity Name:
    OS Therapies Inc
  • Entity Type:
    Corporation
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Over 5 years ago
  • Address:
    115 Pullman Crossing Road
    Suite #103
    Grasonville, MD 21638
  • Persons:
    Related Persons 8
    Paul A. Romness
    Executive Officer, Director 
    Founder, Chairman, President and Chief Executive Officer
    Robert G. Petit
    Executive Officer 
    Chief Medical Officer and Chief Scientific Officer
    Christopher P. Acevedo
    Executive Officer 
    Chief Financial Officer
    Gerald Commissiong
    Executive Officer 
    Chief Business Officer
    John Ciccio
    Director
    Avril McKean Dieser
    Director
    Olivier R. Jarry
    Director
    Theodore F. Search
    Director
EDGAR: Offering Information
  • Accession Date:
    01/21/2025
  • First Sale Date:
    12/31/2024
  • Offering Amount:
    $10,000,000
  • Amount Sold:
    $7,103,000
  • Amount Remaining:
    $2,897,000
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity
  • Sales Clarification:
    After selling $7,103,000 in the Offering, the Issuer has determined to close the Offering.
EFD: Current State Notices

No State Notices found in EFD

EDGAR: Sales Compensation Recipient Information
RecipientCRDBroker DealerBD CRDStates
Brookline Capital Markets 44656 Arcadia Securities, LLC 44656 AL, CA, FL, GA, ID, IL, LA, MD, MN, NV, NJ, NY, TX, VA, WA, WI, WY
Ceros Financial Services, Inc. 37869 None None AL, CA, FL, GA, ID, IL, LA, MD, MN, NV, NJ, NY, TX, VA, WA, WI, WY
EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
OS Therapies Inc/s/Paul A. RomnessPaul A. RomnessChief Executive Officer2025-01-21